Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

An update on an ongoing clinical trial evaluating the performance and safety of Afluxin® in patients with gastroesophageal reflux disease. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afluxin®

Snippet

Sponsor: Devintec Sagl | Conditions: Gastroesophageal Reflux Disease (GERD) | NA | Status: RECRUITING